| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Feb 12, 2024 | Carlyle Group Inc. | 10% Owner | Buy | 100.0 | +190,000 | 21.68% | ✗ | $2.5M |
| Jan 27, 2023 | Jan 31, 2023 | Carlyle Group Inc. | 10% Owner | Buy | 100.0 | +3,133,333 | 55.67% | ✗ | $4.7M |
| Aug 17, 2022 | Aug 19, 2022 | Carlyle Group Inc. | 10% Owner | Sell | 40.0 | -9,925 | -0.33% | ✗ | $201K |
| May 18, 2021 | May 18, 2021 | Vera Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +772,727 | 35.32% | ✗ | $8.5M |
| Oct 20, 2020 | Oct 21, 2020 | Personalis, Inc. | Other | Sell | 17.5 | -130,486 | -3.36% | ✗ | $3.6M |
| Oct 16, 2020 | Oct 20, 2020 | Personalis, Inc. | 10% Owner | Sell | 16.3 | -290,641 | -6.96% | ✗ | $8M |
| Oct 14, 2020 | Oct 16, 2020 | Personalis, Inc. | 10% Owner | Sell | 17.5 | -85,625 | -2.01% | ✗ | $2.3M |
| Oct 12, 2020 | Oct 14, 2020 | Personalis, Inc. | 10% Owner | Sell | 16.3 | -202,360 | -4.53% | ✗ | $5.8M |
| Aug 18, 2020 | Aug 20, 2020 | Personalis, Inc. | 10% Owner | Sell | 15.0 | -986,842 | -18.11% | ✗ | $18.7M |
| Jun 26, 2020 | Jul 6, 2020 | SOLENO THERAPEUTICS INC | 10% Owner | Buy | 100.0 | +3,333,330 | 47.83% | ✗ | $5.5M |
| Oct 25, 2019 | Oct 29, 2019 | SOLENO THERAPEUTICS INC | 10% Owner | Buy | 100.0 | +2,300,000 | 49.26% | ✗ | $2.8M |
| Oct 27, 2014 | Oct 29, 2014 | Protara Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +950,000 | 100.00% | ✗ | $9.5M |
| Apr 17, 2012 | Apr 26, 2012 | AMARIN CORP PLC\UK | 10% Owner | Sell | 15.0 | -4,008,341 | -71.48% | ✗ | $38.5M |
| Apr 17, 2012 | Apr 19, 2012 | AMARIN CORP PLC\UK | 10% Owner | Sell | 15.0 | -4,008,341 | -71.48% | ✗ | $38.5M |
| Apr 3, 2012 | Apr 5, 2012 | AMARIN CORP PLC\UK | 10% Owner | Sell | 15.0 | -2,300,000 | -29.09% | ✗ | $25.3M |